Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low strength anthralin in psoriasis.

L F Montes, W H Wilborn, I Brody

    Journal of Cutaneous Pathology
    |December 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Low strength anthralin ointment effectively treated psoriasis in 130 patients within 4 weeks. This treatment showed significant healing of skin lesions without causing irritation or side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development of vitiligo in children following separation of parents.

    Clinical and experimental dermatology·2008
    Same author

    Cycloheximide in dermatology.

    Acta dermato-venereologica·1997
    Same author

    Gigantic ichthyosis hystrix.

    Journal of the American Academy of Dermatology·1997
    Same author

    Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study).

    American journal of obstetrics and gynecology·1997
    Same author

    Response of leiomyosarcoma to cryosurgery: clinicopathological and ultrastructural study.

    Clinical and experimental dermatology·1995
    Same author

    Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits.

    Cardiovascular research·1993
    Same journal

    Diagnostic Challenge of a White Plaque on the Gingiva: Case Report of Glycogenic Acanthosis.

    Journal of cutaneous pathology·2026
    Same journal

    Elevated IL-4 and IL-13 Expression in Hailey-Hailey Disease: Evidence for Th2-Mediated Pathogenesis and Targeted Treatment.

    Journal of cutaneous pathology·2026
    Same journal

    Blastic Plasmacytoid Dendritic Cell Neoplasm.

    Journal of cutaneous pathology·2026
    Same journal

    Atypical Grover Disease Associated With Merkel Cell Carcinoma: A Novel Paraneoplastic Presentation.

    Journal of cutaneous pathology·2026
    Same journal

    Profile of a Founder: Herbert Zachareus Lund.

    Journal of cutaneous pathology·2026
    Same journal

    The National Resident Match Program Arrives in Dermatopathology: 15 Years of Resilient Advocacy by the American Society of Dermatopathology's Fellowship Training Program Directors' Committee.

    Journal of cutaneous pathology·2026
    See all related articles

    Area of Science:

    • Dermatology
    • Pharmacology

    Background:

    • Psoriasis is a chronic inflammatory skin condition.
    • Effective and safe treatments for psoriasis are continuously sought.

    Purpose of the Study:

    • To evaluate the efficacy and safety of low-concentration anthralin ointment for psoriasis treatment.

    Main Methods:

    • 130 psoriasis patients received daily low-strength anthralin (0.01%-0.03%) ointment.
    • Treatment included UVB light, emollients, bath oil, and antihistamines.
    • Lesion involution was assessed via clinical observation, light microscopy, and electron microscopy (TEM, SEM).

    Main Results:

    • Complete psoriasis clearing was achieved in all patients within an average of 4 weeks.
    • Microscopic analysis revealed significant healing of the stratum corneum and basement membrane.

    Related Experiment Videos

  • Low-strength anthralin demonstrated no irritation, staining, or adverse side effects.

    • Conclusions:

    • Low-concentration anthralin is an effective and safe topical treatment for psoriasis.
    • The treatment promotes rapid healing of psoriatic lesions with minimal side effects.